In patients with severe stroke, use of OACs, compared with no use, was also associated with a NCB although the benefit did not reach statistical significance in the delayed use group.
← all excerpts
Oral Anticoagulation Timing in Patients with Acute Ischemic Stroke and Atrial Fibrillation.
1
—
—